Growth factors and the development of diabetic nephropathy
- PMID: 14611745
- DOI: 10.1007/s11892-003-0012-2
Growth factors and the development of diabetic nephropathy
Abstract
Growth factors play an important role in the development of functional and structural changes associated with diabetic nephropathy. Although it has been known for years that these factors are important for early renal hypertrophy and subsequent development of glomerulosclerosis and tubulointerstitial fibrosis, the exact molecular mechanism of many of these factors has only recently been more elucidated. Furthermore, growth factors also link the metabolic theory of diabetic complications with renal hemodynamic changes in diabetic nephropathy because some growth factors could directly influence glomerular hemodynamics and tubular transport in diabetic nephropathy. The high glucose environment with stimulated cellular uptake of glucose and accelerated nonenzymatic reactions resulting in Amadori-modified proteins and the later-developing advanced glycation end products are the main stimulators for intrarenal induction of growth factors. Intracellular generation of reactive species is an important signal intermediate in these stimulated expressions of growth factors. Taking into consideration the pivotal role of growth factors in the development of diabetic nephropathy, a therapeutic strategy to antagonize growth factor effects appears to be straightforward. However, the pleiotropic function of many of these factors and their physiologic role in normal renal homeostasis may make this approach difficult.
Similar articles
-
Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.Kidney Int. 2001 Jul;60(1):96-105. doi: 10.1046/j.1523-1755.2001.00776.x. Kidney Int. 2001. PMID: 11422741
-
Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor.Curr Opin Nephrol Hypertens. 2001 Nov;10(6):727-38. doi: 10.1097/00041552-200111000-00001. Curr Opin Nephrol Hypertens. 2001. PMID: 11706299 Review.
-
GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.Am J Nephrol. 2013;38(1):39-49. doi: 10.1159/000351989. Epub 2013 Jun 26. Am J Nephrol. 2013. PMID: 23817135 Review.
-
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.Curr Diabetes Rev. 2005 Feb;1(1):27-40. doi: 10.2174/1573399052952622. Curr Diabetes Rev. 2005. PMID: 18220580 Review.
-
CTGF inhibits BMP-7 signaling in diabetic nephropathy.J Am Soc Nephrol. 2008 Nov;19(11):2098-107. doi: 10.1681/ASN.2007111261. Epub 2008 Jul 16. J Am Soc Nephrol. 2008. PMID: 18632843 Free PMC article.
Cited by
-
Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.J Histochem Cytochem. 2019 Sep;67(9):683-699. doi: 10.1369/0022155419851103. Epub 2019 May 22. J Histochem Cytochem. 2019. PMID: 31116066 Free PMC article. Review.
-
Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression.Diabetologia. 2009 Dec;52(12):2642-52. doi: 10.1007/s00125-009-1528-z. Epub 2009 Sep 30. Diabetologia. 2009. PMID: 19789852
-
Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.Diabetes. 2013 Aug;62(8):2923-34. doi: 10.2337/db13-0135. Epub 2013 May 8. Diabetes. 2013. PMID: 23656889 Free PMC article.
-
17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.Am J Physiol Renal Physiol. 2007 Nov;293(5):F1678-90. doi: 10.1152/ajprenal.00079.2007. Epub 2007 Aug 8. Am J Physiol Renal Physiol. 2007. PMID: 17686959 Free PMC article.
-
Advanced glycated end-products affect HIF-transcriptional activity in renal cells.Mol Endocrinol. 2013 Nov;27(11):1918-33. doi: 10.1210/me.2013-1036. Epub 2013 Sep 12. Mol Endocrinol. 2013. PMID: 24030251 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical